OLFM4, LCN2 and FAM3B as Potential Biomarkers for Gut–Brain Axis Dysfunction in IBD-MDD Comorbidity
Genes · 2026
DOI: 10.3390/genes17101245 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2026. Verfasst von Fang Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Translational Research on Cell and Gene Therapy for Higher Education Institutions for Shaanxi Key Laboratory of Higher Education Institutions, Xi'an …. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Neoplasm Proteins, Cytokines, Lipocalin-2. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Xi'an Medical University, Xi’an Medical University.
Abstract (Originalsprache)
Background
Inflammatory bowel disease (IBD) and major depressive disorder (MDD) exhibit bidirectional pathogenic interactions through the gut–immune–brain axis, but robust common biomarkers remain elusive. This study aimed to identify the core hub genes and their conserved signaling pathways in IBD-MDD comorbidity.
Methods
We analyzed two transcriptome datasets, GSE117993 (pediatric IBD biopsy) and GSE98793 (MDD whole blood), to screen for shared differentially expressed genes (DEGs). Multi-algorithm machine learning, marker pathway correlation analysis, immune infiltration assessment and ROC validation were performed.
Results
A total of 25 overlapping DEGs were identified, and three common core genes, OLFM4, LCN2, and FAM3B, were unanimously selected. Marker pathway analysis revealed that these genes were significantly associated with conserved inflammatory cascades in both diseases, including TNF/NF-κB and JAK-STAT signaling pathways, as well as interferon response and metabolic stress pathways. Analysis of immune infiltration indicated an association with neutrophils, M1 macrophages, and other immune subsets. The combined three-gene signature shows preliminary diagnostic performance within these datasets for IBD and MDD.
Conclusions
This study identifies OLFM4/LCN2/FAM3B as potential shared biomarkers hinting at molecular links between IBD and MDD, providing new insights into candidate shared inflammatory mechanisms underlying gut–immune–brain axis dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Research on Cell and Gene Therapy for Higher Education Institutions for Shaanxi Key Laboratory of Higher Education Institutions, Xi'an Medical University, Xi'an 710021, China.
- Medical College of Yan'an University, Yan' an University, Yan'an 716000, China.
- Department of Pharmacy, Xi'an Medical University, Xi'an 710021, China.
Förderung
- National Natural Science Foundation of China
- Xi'an Medical University
- Xi’an Medical University
Zitieren
APA
Li, F., Zhao, J., Song, B., Wang, J., & Zhang, J. (2026). OLFM4, LCN2 and FAM3B as Potential Biomarkers for Gut–Brain Axis Dysfunction in IBD-MDD Comorbidity. Genes. https://doi.org/10.3390/genes17101245
Vancouver
Li F, Zhao J, Song B, Wang J, Zhang J. OLFM4, LCN2 and FAM3B as Potential Biomarkers for Gut–Brain Axis Dysfunction in IBD-MDD Comorbidity. Genes. 2026. doi:10.3390/genes17101245
BibTeX
@article{Li2026,
author = {Li, Fang and Zhao, Junmei and Song, Boyang and Wang, Jiheng and Zhang, Jing},
title = {OLFM4, LCN2 and FAM3B as Potential Biomarkers for Gut–Brain Axis Dysfunction in IBD-MDD Comorbidity},
journal = {Genes},
year = {2026},
doi = {10.3390/genes17101245}
}
EUVIMED